Case number 1:22-cv-00316
Otsuka Pharmaceutical Co., Ltd. v. MSN Laboratories Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 23, 2022 | 11 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2; 10,905,694 B2. (Attachments: # (1) Order)(nms) |
| Jun 23, 2022 | 11 | Order (2) |
| Jun 21, 2022 | 10 | Order (2) Docket Text: SO ORDERED Granting [9] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 6/21/2022. (nms) |
| Jun 14, 2022 | 9 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) |
| Jun 3, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For MSN Laboratories Private Limited waiver sent on 6/1/2022, answer due 8/1/2022. (Tigan, Jeremy) |
| Jun 3, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For MSN Pharmaceuticals Inc. waiver sent on 6/1/2022, answer due 8/1/2022. (Tigan, Jeremy) |
| Mar 16, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Mar 10, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3822074.) - filed by Otsuka Pharmaceutical Co., Ltd. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(apk) |
| Mar 10, 2022 | 1 | Exhibit A-B (33) |
| Mar 10, 2022 | 1 | Civil Cover Sheet (2) |
| Mar 10, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Mar 10, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/25/2022. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 7/25/2024. (apk) |
| Mar 10, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2 ;10,905,694 B2. (apk) |
| Mar 10, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (apk) |
| Mar 10, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to MSN Laboratories Private Limited on 3/10/2022; MSN Pharmaceuticals Inc. on 3/10/2022. (Attachments: # (1) Summons Issued)(apk) |
| Mar 10, 2022 | 6 | Summons Issued (2) |
| Mar 10, 2022 | 1 | Complaint* (1) |
